Q&A with Kathy Lynch, VP of Global Government Affairs & Public Policy at Illumina
Evidence Street® issues review supporting Whole Genome Sequencing
Families facing rare diseases often spend years pinpointing the problem in solitude – until now
New survey finds Americans unaware of DNA's power to improve lives
Graduate Companies Have Raised $190 million in Funding from Leading Life Science and Tech Investors
| Date | Publication | Title |
|---|---|---|
| 27-Feb-2019 | Bloomberg | A $100 Genome Within Reach, Illumina CEO Asks If World Is Ready |
| 27-Feb-2019 | Slate | Why Are We So Afraid of Each New Advance in Reproductive Technology? |
| 19-Feb-2019 | San Diego Union Tribune | San Diego biotech company teams up with doctors to offer genome sequencing to Tijuana children |
| 08-Jan-2019 | Genetic Engineering & Biotechnology News | Illumina CEO Talks $100 Genome, Tariffs, and NovaSeq at J.P. Morgan |
| 05-Dec-2018 | BBC | Faster diagnosis from 'transformational' gene project |
At Illumina, we push boundaries. We think beyond the conventional. We dream big. With the energy of so many bright and accomplished people, the opportunities are endless.
Search for JobsIf you are a member of the media:
If you are not a member of the media, please visit Contact Us.